Bingbing Zhu

Beijing, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 20 publications

Pathogenic Ifit1+ neutrophils driven by IRF7 promote liver injury and represent a therapeutic target in acute liver failure.

Pathogenic Ifit1+ neutrophils driven by IRF7 promote liver injury and represent a therapeutic target in acute liver failure.

Journal: Hepatology (Baltimore, Md.)

Published: October 28, 2025

Relative change rate of liver stiffness measurements predicts the risk of liver decompensation in compensated advanced chronic liver disease.

Relative change rate of liver stiffness measurements predicts the risk of liver decompensation in compensated advanced chronic liver disease.

Journal: Clinical and experimental medicine

Published: June 21, 2025

Alterations in Gut Microbiota and Metabolism in Cirrhotic Portal Hypertension: Implications for Disease Progression.

Alterations in Gut Microbiota and Metabolism in Cirrhotic Portal Hypertension: Implications for Disease Progression.

Journal: Alimentary pharmacology & therapeutics

Published: February 19, 2025

The actual performance of large language models in providing liver cirrhosis-related information: A comparative study.

The actual performance of large language models in providing liver cirrhosis-related information: A comparative study.

Journal: International journal of medical informatics

Published: December 11, 2024

Advances in intrahepatic and extrahepatic vascular dysregulations in cirrhotic portal hypertension.

Advances in intrahepatic and extrahepatic vascular dysregulations in cirrhotic portal hypertension.

Journal: Frontiers in medicine

Published: October 22, 2024

Neutrophil Extracellular Trap Scores Predict 90-Day Mortality in Hepatitis B-Related Acute-on-Chronic Liver Failure.

Neutrophil Extracellular Trap Scores Predict 90-Day Mortality in Hepatitis B-Related Acute-on-Chronic Liver Failure.

Journal: Biomedicines

Published: August 14, 2024

Prognostic and therapeutic potential of imbalance between PD-1+CD8 and ICOS+Treg cells in advanced HBV-HCC.

Prognostic and therapeutic potential of imbalance between PD-1+CD8 and ICOS+Treg cells in advanced HBV-HCC.

Journal: Cancer science

Published: August 17, 2023

Gut microbiota dysbiosis with hepatitis B virus liver disease and association with immune response.

Gut microbiota dysbiosis with hepatitis B virus liver disease and association with immune response.

Journal: Frontiers in cellular and infection microbiology

Published: January 28, 2023

Serum cytokine and chemokine profiles and disease prognosis in hepatitis B virus-related acute-on-chronic liver failure.

Serum cytokine and chemokine profiles and disease prognosis in hepatitis B virus-related acute-on-chronic liver failure.

Journal: Frontiers in immunology

Published: December 29, 2022

A novel prognostic model for predicting the risk of first variceal hemorrhage in patients with HBV-related cirrhosis.

A novel prognostic model for predicting the risk of first variceal hemorrhage in patients with HBV-related cirrhosis.

Journal: Frontiers in cellular and infection microbiology

Published: October 05, 2022

CD200R Combined Neutrophil-Lymphocyte Ratio Predict 90-Day Mortality in HBV-Related Acute-On-Chronic Liver Failure.

CD200R Combined Neutrophil-Lymphocyte Ratio Predict 90-Day Mortality in HBV-Related Acute-On-Chronic Liver Failure.

Journal: Frontiers in medicine

Published: August 21, 2021

Yindan Jiedu granules exhibit anti-inflammatory effect in patients with novel Coronavirus disease (COVID-19) by suppressing the NF-κB signaling pathway.

Yindan Jiedu granules exhibit anti-inflammatory effect in patients with novel Coronavirus disease (COVID-19) by suppressing the NF-κB signaling pathway.

Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology

Published: March 26, 2021

Showing 1-12 of 20

Last Updated: 09/26/2026